Efficacy of Acceptance and Commitment Therapy on Breast Cancer Female Patients’ Hope
Journal Title: International Journal of Cancer Management - Year 2017, Vol 10, Issue 2
Abstract
Background Breast cancer is one of the most serious diseases that can endanger physical, psychological, and social health of women suffering from this disease. Objectives The aim of this study was to evaluate the effectiveness of commitment and acceptance (ACT) on breast cancer patients’ hope. Methods This quasi-experimental study included all patients with breast cancer who were inhibited in Yazd, Iran. Using convenience sampling, 34 patients were selected and randomly divided into two groups: the treatment group and the control group. Both groups completed Miller’s questionnaire on hope. Treatment group received psychological therapy of ACT for 12 weeks, 3 hours per week. Miller’s questionnaire was redistributed and completed again by both groups after completion of the treatment. The collected data were analyzed by SPSS software and running analysis of covariance. Results The results of the current study revealed significant differences between control and treatment groups in terms of pre-test and post-test scores (P = 0.05). Conclusions According to the results of the present study, psychological therapy of ACT can be useful in promoting the breast cancer patients’ hope.
Authors and Affiliations
Abbas Montazer, Fateme Nemati, Fahimeh Dehghani, Tahereh Fallah
Keywords
Related Articles
- EP ID EP237299
- DOI 10.5812/ijcp.5526
- Views 84
- Downloads 0
Effect of Simultaneous Treatment with Royal Jelly and Doxorubicin on the Survival of the Prostate Cancer Cell Line (PC3): An In Vitro Study
Background: Doxorubicin (DOX) therapy is the first step in the treatment of several malignancies such as prostate cancer. Drug resistance is the main drawback of this agent. Royal jelly (RJ), used to prevent or cure many...
Association Between Cytochrome 1B1*3 Polymorphism and the Breast Cancer in a Group of IranianWomen
Background: As a hormone-dependent cancer, estrogen is involved in the development of breast cancer. CYP1B1 belongs to the P450 superfamily of enzymes and is involved in the metabolism of estrogen. The present study inve...
Co-Administration of Anti-Angiogenic Peptide and DNA Vaccine in Cervical Cancer Tumor Model
Background Cervical cancer is one of the main causes of women’s death in the world. Human papilloma virus (HPV) types 16 and 18 have been known as a cause of more than 2/3 of cerv...
Promoter Hypermethylation Analysis of the Tumor Suppressor Genes RASSF1A and RASSF2A in Iranian Endometrial Carcinoma Patients
Introduction The endometrial cancer (EC) is the seventh most common malignancies worldwide among females with good prognosis in early stages of the disease. The CpG Island in the...
Topical Calcineurin Inhibitors and Malignancy Risk
Context The approval of topical calcineurin inhibitors (TCIs) has been a significant breakthrough for the treatment of atopic dermatitis due to much lower systemic absorption and...